FSSNX
Price
$27.77
Change
-$0.31 (-1.10%)
Updated
Sep 20 closing price
GCSUX
Price
$31.14
Change
-$0.32 (-1.02%)
Updated
Sep 20 closing price
Ad is loading...

FSSNX vs GCSUX

Header iconFSSNX vs GCSUX Comparison
Open Charts FSSNX vs GCSUXBanner chart's image
Fidelity Small Cap Index
Price$27.77
Change-$0.31 (-1.10%)
VolumeN/A
CapitalizationN/A
Goldman Sachs Small Cap Eq Insghts R6
Price$31.14
Change-$0.32 (-1.02%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FSSNX vs GCSUX Comparison Chart
Loading...
VS
FSSNX vs. GCSUX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSSNX is a StrongBuy and GCSUX is a Buy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.3B vs. GCSUX (445M). FSSNX pays higher dividends than GCSUX: FSSNX (1.36) vs GCSUX (0.71). FSSNX was incepted earlier than GCSUX: FSSNX (13 years) vs GCSUX (9 years). GCSUX is a more actively managed with annual turnover of: 145.00 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than GCSUX: FSSNX (0) vs GCSUX (5000000). GCSUX annual gain was more profitable for investors over the last year : 30.32 vs. FSSNX (22.65). FSSNX return over 5 years is better than : 44.62 vs. GCSUX (20.49).
FSSNXGCSUXFSSNX / GCSUX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years9 years-
Gain YTD9.97217.27058%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets27.3B445M6,135%
Annual Yield % from dividends1.360.71191%
Returns for 1 year22.6530.3275%
Returns for 3 years0.65-11.74-6%
Returns for 5 years44.6220.49218%
Returns for 10 years84.24N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD3.490.05
+1.45%
Relmada Therapeutics
BSAC20.240.18
+0.90%
Banco Santander-Chile
ODC67.85-0.79
-1.15%
Oil-Dri Corp
HRMY38.34-0.47
-1.21%
Harmony Biosciences Holdings
THAR2.94-0.05
-1.67%
Tharimmune Inc.